Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Find a weight loss dietitian who accepts your insurance
The dual-action peptides send signals to the brain, affecting appetite and metabolism, making it easier for patients who have historically struggled with weight loss
S., Xia, Z., et al
Those outcomes cost far more to manage than obesity itself, and experts warn the state may ultimately spend more as patients lose stability and require intensive care
Injectable options with established authorisation: Semaglutide 2.4 mg (Wegovy) : A once-weekly GLP-1 receptor agonist injection authorised by the MHRA for chronic weight management
US$ 28.73
US$ 25.07
US$ 26.61
US$ 25.24
